Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)

Catalog No.
F1122
Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Cudarolimab (IBI101) is a fully human anti-OX40 (CD134, a co-stimulatory molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has anti-tumor activity and can be used in cancer-related research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

2244739-29-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

IBI-101, IBI101

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P43489

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human TNFRSF4 His at 2 ug/mL can bind Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)

Target

TNFRSF4 / OX40 / CD134

Note

Please avoid freeze-thaw cycles.